Clinical trials for Lymphoma
101 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lymphoma
#NCT06588478
#2024-515689-15-01
Required histologic types
B cell lymphoma
Required histologic sub types
Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2
Lymphoma
#NCT06588478
#2024-515689-15-01
Required histologic types
B cell lymphoma
Required histologic sub types
Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2
Lymphoma
CLL & Richter's syndrome
#NCT04728893
#2023-504931-42-00
Required histologic types
B cell lymphoma
CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 2
Lymphoma
#NCT04728893
#2023-504931-42-00
Required histologic types
B cell lymphoma
Required histologic sub types
Waldenström lymphoma
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Chemotherapy
Targeted therapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 2
Lymphoma
#NCT04920617
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Indolent transformed lymphoma
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
9 recruiting sites
ImmunoVaccine Technologies, Inc.
Phase 2
Lymphoma
#NCT04128072
Required histologic types
T cell lymphoma
Required histologic sub types
Cutaneous T-cell lymphoma
Required disease stage
Early (stage I and II)
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
2 recruiting sites
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 1 / Phase 2
Lymphoma
#NCT07018752
#2024-514954-63-00
Toutes sous études
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min
50-60 ml/min
30-50 ml/min
Required number of previous lines of therapy
1
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
20 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 1 / Phase 2
Lymphoma
#NCT07607925
Required histologic types
B cell lymphoma
Required disease stage
Disseminated (stage III and IV)
Required central nervous system lesions
None
Treated / Controled
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Chemotherapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
GlaxoSmithKline
Phase 1 / Phase 2
Lymphoma
#NCT07519772
#2025-523005-15-00
Lymphome folliculaire
Required histologic types
B cell lymphoma
Required histologic sub types
Follicular lymphoma
Required central nervous system lesions
None
Required immunophenotypic profiles
CD19
Required number of previous lines of therapy
2
3 or more
Excluded previous treatments
Systemic Treatment-Naive
1 recruiting site
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Lymphoma
#NCT07519772
#2025-523005-15-00
Lymphome diffus à grandes cellules B
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma
Required central nervous system lesions
None
Required immunophenotypic profiles
CD19
Required number of previous lines of therapy
2
3 or more
Required previous treatments
Car-T
Autologous stem cell transplant
Allogeneic stem cell transplant
Excluded previous treatments
Systemic Treatment-Naive
1 recruiting site
Merck Sharp & Dohme LLC